7:45 AM - 8:45 AM

Registration & Breakfast

8:45 AM - 9:00 AM

Chairman’s Opening Remarks

Smart Pharma: Key Trends That Will Enable The Reshaping of Drug Discovery and Development

Harry Glorikian | Speaking at AI Applications Summit | Biopharma

Harry Glorikian

General Partner New Ventures Funds
9:00 AM - 9:40 AM

Executive Viewpoints: Will AI Be Innovation or Renovation for Biopharma?

Milind Kamkolkar | Speaking at AI Applications Summit | Biopharma

Dr. Milind Kamkolkar

Chief Data Officer VL49 - a Flagship Pioneering Company

Disrupting the Status Quo With Visionary Models For Collaboration

9:40 AM - 10:05 AM

Internal Collaboration: Moving Toward the Value of End-to-End Maching Learning for Pipeline Optimization

10:05 AM - 10:30 AM

The Handbook on how to Find the Right External Partners

Drug Discovery

10:30 AM - 10:55 AM

Early Stage R&D Use Cases

10:55 AM - 11:25 AM

Networking, Refreshments & Expert One-to-One Meetings

11:25 AM - 11:50 AM

Late Stage R&D Use Cases

11:50 AM - 12:15 PM

Employing AI to find the Translational Piece for Making Drugs Effective, Validated and Useful in Humans

Gina Deshpande | Speaker | AI Applications Summit

Gini Deshpande, PhD

CEO & Founder NuMedii
12:15 PM - 1:15 PM

Networking Lunch & Expert One-to-One Meetings

AI for Clinical Development

1:15 PM - 1:40 PM

Using Deep Learning to Improve Drug Development Success Outcomes

This session will look at how AI technology such as Deep Learning is being applied to the challenge of drug failure, both in discovery and in clinical trials. One of the primary drivers of R&D expense is the high number of failures that occur during the development of a therapeutic. Many pharmaceutical companies are now looking at AI solutions to better predict which assets will succeed in trials, and to design compounds have been optimized for success. Some specific examples:

  • Using clinical trial outcomes to improve estimates of success.
  • Currently approximately 50% of trials fail due to ADME/Tox issues – examples of how Pfizer is using
  • DL to help change this.
  • How is medicinal chemistry and design changing with AI?
  • Using AI earlier in the discovery cycle to select targets and indications for investment.
Michael G Frank | Speaker | AI Applications Summit

Michael G. Frank

Director, World Wide R&D Strategy Pfizer
1:40 PM - 2:05 PM

Virtual Trials

2:05 PM - 2:35 PM

Getting to the Proof of Innovation: Case Studies From AI Use in Clinical Trials

2:35 PM - 3:05 PM

Afternoon Refreshments & Expert One-to-One Meetings

Deep Dive Concurrent Sessions

3:05 PM - 3:55 PM

Clinical Development


Mohammed Ali | Speaker | AI Applications Summit

Mohammed Ali

Global Head Digital Trials- Global Clinical Operations Boehringer Ingelheim Pharmaceuticals, Inc.

Data Democratization & Interopability


4:00 PM - 4:25 PM

An AI Powered Project: Human Genetics & Drug Discovery

4:25 PM - 5:00 PM

Innovation Spotlight Changemaker Presentations


Travis McCready | Speaker | AI Applications Summit

Travis A. McCready

President & CEO Massachusetts Life Sciences Center

Changemaker Presenter

David Wild, Ph.D | Speaker | AI Applications Summit

David Wild, Ph.D.

Founder & President Data2Discovery Inc
5:00 PM - 6:00 PM

Evening Reception

8:00 AM - 9:00 AM

Breakfast & Expert One-to-One Meetings

Real-World Evidence

9:00 AM - 9:25 AM

Overcoming Barriers to RWE Adoption and Realizing Value

Charles Makin | Speaker | AI Applications Summit

Charles Makin

Global Head, Real World Evidence Strategy Biogen
9:25 AM - 9:50 AM

Innovate Practically: Finding the Intersections Between AI and RWE to Better Treat Patients

Chris Boone Ph.D | Speaker | AI Applications Summit

Christopher Boone, Ph.D, FACHE

Vice President, Head of Real World Data and Analytics Center of Excellence Pfizer
9:50 AM - 10:15 AM

FDA Update on Using RWE

Data Management

10:15 AM - 10:40 AM

Data Diversity and Access: Impacting Patients in Meaningful Ways and Avoiding Data Biases

Gabriela Lavezzari

Senior Director, US R&D Policy & Scientific Affairs, R&D Strategy, Portfolio & Operations GSK
10:40 AM - 11:10 AM

Morning Refreshments & Expert One-to-One Meetings

11:10 AM - 11:35 AM

Data Organization and Communication: Unlocking the Value of Insights

This session features two case study presentations that will address the importance of data organization across an organization to unlock the value of the data being collected.
• Why one-size-fits-all systems don’t work (at least right now).
• Janssen’s “ecosystem of platforms” approach to taking existing systems for different purposes and integrating them for better data access
• Methods for capturing data sets to do analysis across the company instead of in silos.
• A view into current Janssen projects.

Joseph Lehar | Speaker | AI Applications Summit

Joseph Lehar

VP of Data Science, Oncology The Janssen Pharmaceutical Companies of Johnson & Johnson
11:35 AM - 12:00 PM

Creating Strong Staffing and Culture Models to Effectively Produce Transformative Therapies Faster

12:00 PM - 12:40 PM

Open Discussion: New Collaborative Models to Impact Patients in More Meaningful Ways

12:40 PM - 12:45 PM

Chair's Closing Remarks